条形多巴胺载体吸收的纵向变化与患有勒维体痴呆症的临床特征之间的关联
Ryo Yamamoto1, Naoto Takenoshita1, Yuta Inagawa1
1Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.
概括
患有莱维体痴呆症 (DLB) 患者的多巴胺转运体 (DaT) 摄取量减少. 帕金森症和认知功能的纵向变化与DaT吸收相关,特别是在骨中.
科学领域:
- 神经学 神经学
- 核医学就是核医学.
- 老年医学 老年医学
背景情况:
- 勒维体痴呆症 (DLB) 的特点是条纹性I-2β-Carbomethoxy-3β-(4-iodophenyl) -N-(3-) 诺特罗潘 (I-FP-CIT) 多巴胺载体单光子发射断层扫描 (DaT-SPECT) 的摄取率较低.
- 在患有帕金森症的DLB患者中,纵向临床变化和DaT摄入之间的关联以前没有被研究过.
研究的目的:
- 研究DLB患者的DaT摄入量纵向变化与帕金森症和认知功能的严重程度之间的关联.
主要方法:
- 一组35名可能的DLB门诊患者在2014年4月至2020年9月期间接受了两次DaT-SPECT扫描.
- 每年对DaT摄入量的变化与临床特征相关,包括认知能力下降和帕金森症.
主要成果:
- 在帕金森症严重程度的年度变化和左后门的DaT吸收之间发现了显著的负相关性 (r = -0.39,P = 0.03).
- 迷你精神状态检查得分与在大多数大脑区域的DaT吸收相关,除了右后骨 (P <0.05).
结论:
- 这项研究表明,黑色物质到门通路对于DLB的运动功能至关重要.
- 纵向的DaT-SPECT发现可能反映疾病进展,并与DLB患者的临床衰退相关.
更多相关视频
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.4K
11:26Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Published on: September 21, 2017
12.5K
相关概念视频
01:26Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
01:30Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
01:15Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
01:24Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K